TLR4 and metabolic dysfunction-associated steatohepatitis: Moreover, in NAFLD/NASH animal models the disruption of intestinal integrity leads to increased LPS translocation, TLR-4 signalling activation, hepatic inflammation and fibrogenesis [6].